Primary aldosteronism: The case for screening

Nature Clinical Practice Nephrology

Volumn 3, Issue 11, 2007, Pages 582-583

  Gordon, Richard D ^a   Stowasser, Michael ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; AMILORIDE; FLUDROCORTISONE; GLUCOCORTICOID; RENIN; SPIRONOLACTONE;

ADRENAL GLAND; ADRENALECTOMY; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR EFFECT; COST; DECISION MAKING; DEVELOPING COUNTRY; DISEASE COURSE; ESSENTIAL HYPERTENSION; HUMAN; LABORATORY TEST; MEDICAL PRACTICE; MEDICARE; OUTCOME ASSESSMENT; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SCREENING; SHORT SURVEY;

HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MASS SCREENING;

EID: 35548931236     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0626     Document Type: Short Survey

References (11)

1. Mulatero P et al. (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89: 1045-1050
2. Newton-Cheh C et al. (2007) Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 49: 846-856
3. Rossi GP et al. (1997) Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 95: 1471-1478
4. Stowasser M and Gordon RD (2006) Aldosterone assays: an urgent need for improvement. Clin Chem 52: 1640-1642
5. Mulatero P et al. (2002) Drug effects on aldosterone/ plasma renin activity ratio in primary aldosteronism. Hypertension 40: 897-902
6. Stowasser M and Gordon RD (2003) Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 17: 591-605
7. Rossi GP et al. (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48: 2293-2300
8. Celen O et al. (1996) Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 131: 646-650
9. Mahmud A et al. (2005) Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone? Am J Hypertens 18: 1631-1635
10. Hood SJ et al. (2007) The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Circulation 116: 268-275
11. Stowasser M and Gordon RD (2003) Primary aldosteronism: from genesis to genetics. Trends Endocrinol Metab 14: 310-317